Effects of oral glucocorticoid therapy on CD4+CD25+CD127- and CD4+CD25high T cell levels in asthmatic patients.
Moniuszko
Marcin
M
Department of Allergology and Internal Medicine, Medical University of Bialystok, Sklodowskiej-Curie Street 24A, Bialystok, Poland. moniuszm@umwb.edu.pl
Bodzenta-Lukaszyk
Anna
A
Dabrowska
Milena
M
D000328:Adult; D000402:Airway Obstruction / Q000276:immunology; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D045853:Exhalation / Q000276:immunology; D005434:Flow Cytometry; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D053645:Interleukin-2 Receptor alpha Subunit; D053699:Interleukin-7 Receptor alpha Subunit; D008213:Lymphocyte Activation; D018655:Lymphocyte Count; D008875:Middle Aged; D009569:Nitric Oxide / Q000032:analysis; D012720:Severity of Illness Index; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology
D018927:Anti-Asthmatic Agents; D005938:Glucocorticoids; D053645:Interleukin-2 Receptor alpha Subunit; D053699:Interleukin-7 Receptor alpha Subunit; D009569:Nitric Oxide